Testing in Europe, Latin-America and Asia
International testing of medication packaging
Duration of this project: 6 months
LiCalab has built an international network of living labs. We explored a new design for medication packaging for a large pharmaceutical company with partners from other EU countries, such as the Netherlands, the UK, Italy, Denmark, Slovenia and France (2015), as well as Asia and Latin-America (2016).
Co-creation with patients and professionals
Based on the results of the co-creation sessions with patients, pharmacists and nurses, the company developed three new designs. These were tested among 20 patients and 10 pharmacists in 5 EU countries (2015). The new packaging is currently on the market in the Netherlands.
Validation of new design in Latin-America, Asia and Australia
In 2016, the company asked LiCalab to investigate whether this European design would also work in a different culture and context, i.e. in Latin-America, Asia and Australia. What about colours and colour associations? Are warning symbols interpreted the same way? LiCalab and Applied Psychology at Thomas More developed a study that was conducted in Australia, Japan, China, Brazil, Colombia and Mexico in November 2016. In each country the participants were patients and healthcare providers.